How long do you want to live? 80 years, 120 years, 150 years, or forever are possible answers to this question that bestselling science writer David Ewing Duncan, the author of Experimental Man, asked 30,000 people in his new TED e-book, "When I'm 164: The New Science of Radical Life Extension, and What Happens If It Succeeds".
While riffing on the Beatle's song "When I'm 164," the book surveys the increasingly legitimate science of radical life extension—from Healthy Living and Genetics to Regeneration and Machine Solutions—and considers the pluses and minuses of living to age 164, or beyond; everything from the impact on population and the cost of living to what happens to love, curiosity, and health. He shares classic stories and myths of people determined to defeat aging and death, and offers real-life tales of the techno-heroes and optimists who believe that technology can solve the "problem" of aging. Concluding that anti-aging technologies will probably succeed in the next 30-50 years despite his earlier skepticism, he brings us back to the age-old question: "will you still need me, will you still feed me, when I'm..."
David Ewing Duncan, a best-selling author of eight books and an award-winning science journalist, is dedicated to exploring leading-edge science and technology, and its consequences in the present and in the future. A prolific writer, editor, commentator and television correspondent for NPR, ABC Nightline, NOVA, National Geographic, Wired, and many others, Duncan is famous for translating cutting-edge science and technology into provocative, accessible and entertaining content.
He founded the Center for Life Science Policy at UC Berkeley to focus on studies and initiatives on topics ranging from personalized medicine to extending human lifespan; the politics of stem cells; and the integration of environmental studies with human bioscience. Duncan is also the Founder of the BioAgenda Institute, an independent, non-profit program of events and educational initiatives that discusses and analyzes crucial issues in life sciences.
Duncan has always sought out stories and issues where clashes of ideas, cultures and discoveries occur. Chief Correspondent of NPR Talk's Biotech Nation and a former commentator for NPR's Morning Edition, Duncan is also a correspondent for Atlantic.com. He was a former contributing editor to Condé Nast Portfolio and was the "Natural Selection" science columnist for Portfolio.com. In addition, Duncan regularly contributes to National Geographic, Fortune, Wired, The New York Times, Atlantic Monthly, Smithsonian, and many others. He has won numerous awards including the Magazine Story of the Year from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing.